| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,323,049 |
| 52
Week Range: |
$0.937 - $1.235 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-09-20 |
4 |
AS |
$12.50 |
$60,000 |
D/D |
(4,800) |
2,328,134 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-09-19 |
4 |
AS |
$12.74 |
$420,394 |
D/D |
(33,000) |
2,332,934 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-09-18 |
4 |
AS |
$13.02 |
$429,591 |
D/D |
(33,000) |
2,365,934 |
|
- |
|
| Keller Joseph Kenneth |
EVP & Chief Operating Officer |
• – – |
2012-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
128,000 |
|
- |
|
| Keller Joseph Kenneth |
EVP & Chief Operating OfficerO |
• – – |
2012-09-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,000 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-09-06 |
4 |
AS |
$12.63 |
$429,335 |
D/D |
(34,000) |
2,398,934 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-09-05 |
4 |
AS |
$12.53 |
$413,573 |
D/D |
(33,000) |
2,432,934 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-09-04 |
4 |
AS |
$12.01 |
$60,040 |
D/D |
(5,000) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-09-04 |
4 |
OE |
$6.65 |
$33,250 |
D/D |
5,000 |
7,250 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2012-08-17 |
4 |
S |
$12.58 |
$72,335 |
D/D |
(5,750) |
0 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-08-16 |
4 |
AS |
$12.61 |
$1,058,887 |
D/D |
(84,000) |
2,465,934 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-08-15 |
4 |
AS |
$12.54 |
$1,040,447 |
D/D |
(83,000) |
2,549,934 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-08-14 |
4 |
AS |
$12.53 |
$519,995 |
D/D |
(41,500) |
2,632,934 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-08-09 |
4 |
OE |
$1.06 |
$79,163 |
D/D |
75,000 |
2,674,434 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-07-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
6,436 |
1,484,106 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2012-07-13 |
4 |
S |
$16.27 |
$82,370 |
D/D |
(5,000) |
5,750 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-07-12 |
4 |
OE |
$1.47 |
$100,000 |
D/D |
68,027 |
2,605,870 |
|
- |
|
| Gagnon Gilles |
Director |
– • – |
2012-03-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| Gueth Anton |
Director |
– • – |
2012-03-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-03-06 |
4 |
S |
$12.70 |
$31,750 |
D/D |
(2,500) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-03-06 |
4 |
OE |
$2.55 |
$6,375 |
D/D |
2,500 |
4,750 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-03-05 |
4 |
S |
$12.83 |
$41,056 |
D/D |
(3,200) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-03-05 |
4 |
OE |
$2.55 |
$8,160 |
D/D |
3,200 |
5,450 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2012-01-14 |
4 |
D |
$14.63 |
$246,486 |
D/D |
(16,848) |
2,490,517 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2011-12-29 |
4 |
OE |
$1.43 |
$678,406 |
D/D |
205,836 |
2,507,365 |
|
- |
|
658 Records found
|
|
Page 22 of 27 |
|
|
